- Home
- MLGO vs TARA Comparison
MLGO vs TARA Comparison
Compare MLGO & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLGO
- TARA
- Stock Information
- Founded
- MLGO 2018
- TARA N/A
- Country
- MLGO China
- TARA United States
- Employees
- MLGO N/A
- TARA N/A
- Industry
- MLGO EDP Services
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MLGO Technology
- TARA Health Care
- Exchange
- MLGO Nasdaq
- TARA Nasdaq
- Market Cap
- MLGO 99.2M
- TARA 118.1M
- IPO Year
- MLGO N/A
- TARA N/A
- Fundamental
- Price
- MLGO $8.50
- TARA $3.23
- Analyst Decision
- MLGO
- TARA Strong Buy
- Analyst Count
- MLGO 0
- TARA 6
- Target Price
- MLGO N/A
- TARA $19.80
- AVG Volume (30 Days)
- MLGO 355.2K
- TARA 159.0K
- Earning Date
- MLGO 09-18-2025
- TARA 08-11-2025
- Dividend Yield
- MLGO N/A
- TARA N/A
- EPS Growth
- MLGO N/A
- TARA N/A
- EPS
- MLGO 16.40
- TARA N/A
- Revenue
- MLGO $74,185,505.00
- TARA N/A
- Revenue This Year
- MLGO N/A
- TARA N/A
- Revenue Next Year
- MLGO N/A
- TARA N/A
- P/E Ratio
- MLGO $0.54
- TARA N/A
- Revenue Growth
- MLGO N/A
- TARA N/A
- 52 Week Low
- MLGO $8.13
- TARA $1.60
- 52 Week High
- MLGO $972.00
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- MLGO 35.28
- TARA 54.35
- Support Level
- MLGO $8.31
- TARA $3.08
- Resistance Level
- MLGO $9.46
- TARA $3.32
- Average True Range (ATR)
- MLGO 0.62
- TARA 0.16
- MACD
- MLGO 0.61
- TARA 0.01
- Stochastic Oscillator
- MLGO 16.97
- TARA 74.29
About MLGO MicroAlgo Inc.
MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).